While Hims & Hers Health Inc has overperformed by 4.54%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, HIMS rose by 152.46%, with highs and lows ranging from $72.98 to $11.20, whereas the simple moving average jumped by 43.48% in the last 200 days.
On February 18, 2025, Morgan Stanley Downgraded Hims & Hers Health Inc (NYSE: HIMS) to Equal-Weight. A report published by Citigroup on January 10, 2025, Downgraded its rating to ‘Sell’ for HIMS. BTIG Research also rated HIMS shares as ‘Buy’, setting a target price of $35 on the company’s shares in an initiating report dated January 07, 2025. Morgan Stanley Initiated an Overweight rating on December 17, 2024, and assigned a price target of $42. BofA Securities November 14, 2024d its ‘Buy’ rating to ‘Underperform’ for HIMS, as published in its report on November 14, 2024. Needham’s report from August 22, 2024 suggests a price prediction of $24 for HIMS shares, giving the stock a ‘Buy’ rating. Imperial Capital also rated the stock as ‘In-line’.
Analysis of Hims & Hers Health Inc (HIMS)
Further, the quarter-over-quarter increase in sales is 95.09%, showing a positive trend in the upcoming months.
One of the most important indicators of Hims & Hers Health Inc’s future performance is equity, which can be evaluated using several well-rounded types of analysis and research techniques. The goal here is to ensure that your current return on equity of 30.71% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 1.50, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
For any stock, average volume can also provide valuable insight into volatility, and HIMS is recording 19.83M average volume. On a monthly basis, the volatility of the stock is set at 13.75%, whereas on a weekly basis, it is put at 13.33%, with a loss of -20.27% over the past seven days. Furthermore, long-term investors anticipate a median target price of $45.19, showing growth from the present price of $35.95, which can serve as yet another indication of whether HIMS is worth investing in or should be passed over.
How Do You Analyze Hims & Hers Health Inc Shares?
The Household & Personal Products market is dominated by Hims & Hers Health Inc (HIMS) based in the USA. When comparing Hims & Hers Health Inc shares with other companies under Consumer Defensive, the P/E value is an influential factor to note. This is because it represents an indication of the future growth of the company in terms of investors’ expectations. Ultimately, the value of the latter should demonstrate steady, rapid growth, which is an accurate measure of the company’s progress. In addition to the value of 67.22, there is a growth in quarterly earnings of 1830.36%.
Along with the fundamentals, it is also important to consider how many employees own shares of the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 18.32%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 73.74% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
HIMS shares are owned by institutional investors to the tune of 73.74% at present.
